Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed (Zhejiang Vacin Bio-Pharmaceutical)

吸附无细胞百白破联合疫苗（艾美卫信生物药业）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDiphtheria, Tetanus and Acellular Pertussis Combined Vaccine, Adsorbed (Zhejiang Vacin Bio-Pharmaceutical)
Drug Alias NameN/A
ClassificationVaccines > Vaccine type > Combination vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTetanusDiphtheriaWhooping Cough
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaPending
Originator CompaniesAimei Weixin BioPharm (Zhejiang) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAimei Weixin BioPharm (Zhejiang) Co Ltd
Active IndicationsN/A
Inactive IndicationsTetanusDiphtheriaWhooping Cough

Other Information

ATC CodeN/A
Related LinksN/A